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Stigmatization is a major burden in adult psychiatric patients with Axis-I diagnoses, as
shown consistently in most studies. Significantly fewer studies on the emergence of
psychiatric stigma in adult patients with personality disorders (PDs) exist, although the
resulting evidence is conclusive. Some authors consider patients with PDs at risk for
severe stigmatization because of intense difficulties during interpersonal contact, even in a
psychotherapeutic relationship. The aim of this study was primarily the assessment of pre-
existing stigma in patients referred for intensive treatment for PDs. The study enrolled 214
patients admitted to the adult department of a highly specialized mental health care insti-
tute offering psychotherapy for patients with severe and complex personality pathology.
All patients underwent a standard assessment with self-report questionnaires and a semi-
structured interview to measure Axis II PDs. The stigma consciousness questionnaire
and the perceived devaluation-discrimination questionnaire, both validated instruments,
were used to measure perceived and actual experiences of stigma. Independent sample
t-tests were used to investigate differences in the mean total stigma scores for patients
both with and without a PD. One-way ANOVAs were performed to assess the differences
between having a borderline PD, another PD, or no PD diagnosis. Multiple regression
main effect analyses were conducted in order to explore the impact of the different
PD diagnosis on the level of stigma. The mean scores across all patient groups were
consistent with rather low stigma. No differences were found for patients with or without
a PD diagnosis. Level of stigma in general was not associated with an accumulating
number of PDs. Given the remarkable results, we would strongly recommend further
investigations in the field to better understand the phenomenon of stigma in all its
aspects.
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Introduction
A stigma is defined as a discrediting and disgracing mark that
usually leads to negative behavior in its bearer (1–10). Various
approaches have been used to conceptualize psychiatric stigma
(1–6). The definition and conceptualization of psychiatric stigma
are still in full evolution. Aspects of devaluation, discrimination,
decreased self-esteem, self-restricted behavior, and dysfunctional
coping are almost always mentioned (1–4).
The conclusion that stigmatization is experienced as a major
burden for adult psychiatric patients with Axis-I diagnoses has
been shown consistently inmost studies (7–14). It is also clear that
self-stigma is common; consistently related to social anxiety and
depression; and correlatedwith lower self-esteem, lower therapeu-
tic adherence, and negative quality of life (8, 10, 12, 13). There
are significantly fewer studies on the emergence of psychiatric
stigma in adult patients with personality disorders (PD), although
the existing evidence is conclusive (11, 15). Rüsch et al. found
that borderline patients are vulnerable to higher stigmatization
because of the severity of their conditions, common interpersonal
difficulties, and visible devaluating signs, such as self-mutilation
scars (15). Stigma in borderline patients is associated with lower
self-esteem and other signs of poorer psychological well being
(15). In a qualitative study, Dinos et al. showed that patients with
PD who did not experience overt discrimination, were affected by
patronizing attitudes and stigma anyway (11).
Aviram (16) considers sufferers of PDat risk for severe stigmati-
zation because of the possible intense difficulties triggered by and
experienced during interpersonal contact. Several other studies
(17, 18) emphasize that the belief in a weak or nervous personality
as the cause of mental disorders, is consistently associated with
more stigma. Other authors (19) state that increasing the public
understanding of the biological substrates of mental illness does
not result in a better social acceptance of psychiatric patients.
Interpersonal difficulties between patients and therapists might
also perpetuate negative perceptions in mental health care work-
ers (16). The widespread idea that the behavior of patients with
PD is deliberate and within their control and the misconception
of their rejection of offered help enhance the chance for pejorative,
judgmental, and rejecting attitudes. Especially in the treatment
of borderline patients with frightening symptoms including self-
harm and suicidal attempts, distancing, and self-protection of the
therapist can lead to a self-fulfilling prophecy of more stigmati-
zation and prejudice. Self-esteem and personal empowerment are
basic features in the treatment of PDs and are closely related to
basic assumptions in stigma theories, as mentioned above. Stigma
research (20, 21) also has revealed that self-esteem can medi-
ate between internalized stigma and hope. Promoting personal
empowerment might challenge stigma in a similar way.
A recent study showed that treatment-seeking adolescents with
PD experience more stigma than treatment-seeking adolescents
with other severe and treatment refractory psychiatric disor-
ders (22). Borderline PD was shown to be the strongest predic-
tor of experiences of stigma in this group of treatment-seeking
personality disordered adolescents, when controlled for other
types of personality pathology. Adolescents with a combination
of different kinds of personality diagnoses tend to experience
the highest levels of stigma. The authors suggest that therapists
should be aware of psychiatric stigma when treating these sub-
groups of adolescents with personality problems and discuss its
existence with their patients and families. Psycho-education about
the nature and etiology of PD and treatment prognosis could be
helpful interventions too.
Given the evidence for higher stigma in treatment-seeking
adolescents with PDs, it is legitimate to hypothesize that stigma-
tization in treatment-seeking adults with PDs will be more pro-
nounced than stigmatization in treatment-seeking adults without
PDs. The aim of this study was to assess whether there is a
difference in levels of stigmatization experienced by treatment-
seeking adults diagnosed with PD, in comparison with other
treatment-seeking adults.
Materials and Methods
This study was part of the Study on Cost-Effectiveness of Person-
ality disorder Treatment (SCEPTRE)-trial, a multi-center study
conducted with the purpose of providing data for economic eval-
uation of various psychotherapeutic treatments for adults with
PDs. The studywas registered in theDutch trial register (ISRCTN:
73817429) and received approval of the Medical Ethics Com-
mittee of the Erasmus University Medical Centre (Rotterdam,
Netherlands). All included patients gave informed consent (23).
Inclusion criteria for the study were patients with long existing
psychiatric symptoms suggesting personality pathology. Comor-
bid Axis-I disorders were allowed. Exclusion criteria were patients
with psychotic disorders, severe behavioral disturbances, organic
cerebral impairment, and mental retardation. The stigma-study
enrolled 216 patients from SCEPTRE inDeViersprong. All partic-
ipating SCEPTRE-patients were asked to cooperate in the stigma-
study, but they could easily refuse without giving an explanation.
All patients included in the stigma-trial explicitly provided oral
informed consent to complete the stigma questionnaires. De Vier-
sprong is a highly specialized mental health care institute offering
outpatient, day hospital, and inpatient psychotherapy for adoles-
cents and adults with severe and complex personality pathology.
The majority of patients have a long history of severe psychiatric
symptoms and problems whereby previous treatments were often
unsuccessful. De Viersprong aims to achieve sustainable patient
recovery with innovative and proven cost-effective treatments.
All patients undergo a standard assessment as part of the intake
procedure, to assess the severity of personality problems and to
determine their eligibility for psychotherapeutic treatment. The
intake procedure includes self-report questionnaires to measure
psychopathology, personality, functional impairments, and treat-
ment history, and a semi-structured interview to measure Axis
II PDs. Interviewers were masters-level psychologists who were
thoroughly trained and receivedmonthly booster sessions to avoid
drifting from the interviewer guidelines. Two patients did not
complete the assessment battery as part of the formal admission
procedure, which left 214 patients for the current sample.
Measures
Diagnostic Interview
The structured interview for the DSM-IV personality (SIDP-IV)
(24, 25) was used to measure PDs. This interview covers the 11
formal DSM-IV-TR Axis II PD diagnoses, including personality
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disorder not otherwise specified (PDNOS), two appendix diag-
noses (depressive and negativistic PD), and the DSM-III-R self-
defeating PD. Inter-rater reliability was computed by videotaped
interviews, with percentages of agreement ranging from 84%
(avoidant PD) to 100% (schizoid PD).
Questionnaires Measuring Stigma
The stigma consciousness questionnaire (SCQ) (26) is used to
measure perceived and actual experiences of stereotypes in spe-
cific target groups. It is a validated instrument consisting of 10
items scored on a Likert scale ranging from 1 to 6. The lower
the score, the higher the level of stigma consciousness. A Dutch
translation of the questionnaire was used in this study, and it was
based on a forward and backward translation.
The perceived devaluation-discrimination questionnaire
(DDQ) (27) is used to measure the individual perception of
how “most other people” view individuals with mental illness.
The scale is widely used in stigma research (28), has excellent
psychometric properties, and predicts deterioration in self-
esteem. It consists of 12 items rated on a Likert scale with a range
from 1 (highest awareness) to 6 (lowest awareness). The results of
the scale are obtained by summing the items and dividing by 12.
A Dutch translation of the questionnaire was used in this study
based on a forward and backward translation. Because of an error
in the translation process, one item (question 7) was left out of
the version used in our analyses. There are no data available for
the use of this questionnaire in personality disordered patient
groups. A cohort consisting of adult patients from different
diagnostic categories (schizophrenia, major depressive disorder,
and schizophrenia-like psychotic disorders) all showed mean
scores on the DDQ that were significantly different from the
midpoint with p< 0.001 (29).
Statistical Procedures
Independent sample t-tests were used to investigate differences
in the mean total scores for the questionnaires measuring stigma
for patients both with and without a PD. One-way ANOVAs were
performed to assess the differences between having a borderline
PD, another PD, or no PD diagnosis. Multiple regression main
effect analyses were conducted in order to explore the impact
of the different PD diagnosis on the level of stigma. Age and
gender were also entered in the regression models. To investi-
gate the relationship between accumulative personality pathology
and the level of stigma, we observed the trend in stigma scores




Of the 214 patients admitted to de Viersprong, 133 (62.1%) were
female and 81 were male (37.9%). Participants were 19–67 years
of age with amean age of 33.9 (SD= 10.03). One hundred twenty-
seven patients were formally diagnosed with a PD, from whom 54
had 1 PD, 34 had 2 PDs, and 39 had 3 or more PD. Seventy-seven
patients were not diagnosed with a PD, although all patients in
this group showed at least 7 personality traits on SIDP-IV. PDNOS
was most frequently diagnosed (38.3%), followed by avoidant PD
(22%), depressive PD (19.6%), and borderline PD (13.6%). Schizo-
typal PD and negativistic PD were the least frequently diagnosed
disorders (with both at 0.5%).
The mean SCQ score for the total group of patients was 4.38
(SD= 1.07). The average DDQ score was 4.60 (SD= 0.77). The
mean scores across all patient groups were significantly higher
than the midpoint of the scale, which was consistent with rather
low stigma consequences.
Personality Disorder Versus No Personality
Disorder
As shown in Table 1, no differences were found for patients with
or without a PD diagnosis.
Borderline Personality Disorder Versus Other
Personality Disorder Versus No Personality
Disorder
When assessing the differences on both stigma questionnaires for
having a borderline PD (n= 27–29, for DDQ and SDQ, respec-
tively), another PD (n= 100–102, for DDQ and SDQ, respec-
tively) or no PD (n= 77–78, for DDQ and SDQ, respectively), no
significant differenceswere found between the three groups [SCQ:
F(2,206)= 0.045, p> 0.05; and DDQ: F(2,201)= 0.191, p> 0.05].
Stigma by Type of Personality Disorder
Stigma consciousness questionnaire and DDQ values for the dif-
ferent PD diagnoses are presented in Tables 2 and 3. The results
shown in Table 2 suggest that patients with schizoid PD experi-
ence the highest level of stigma, with a SCQ score of 3.45. No
PD, however, could significantly predict the level of stigma as
measured by the SCQ [F(16,192)= 0.780, p> 0.05]. As for the
results obtained using the DDQ [F(16,187)= 0.983, p> 0.05],
paranoid PD significantly predicted higher levels of experienced
stigma.
TABLE 1 |Mean stigma scores of patients both with and without a PD (n=204–209)a.
Questionnaire Patients with PD (n=127–131)a Patients without PD (n=77–78)a t p d
M (SD) M (SD)
Stigma consciousness questionnaire (SCQ) 4.36 (1.00) (n= 131) 4.41 (1.19) (n=78) 0.280 0.779 0.05
Devaluation-discrimination questionnaire (DDQ) 4.58 (0.76) (n= 127) 4.64 (0.79) (n=77) 0.513 0.608 0.08
PD, personality disorder.
aN varies due to missing values.
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TABLE 2 |Mean SCQ scores for DSM-IV Axis II personality disorders (n=209).
N (%) SCQ M (SD) Analysis
B (SE) CI b
Lower bound Upper bound
Age 0:009 (0:01)  0.007 0.025 0:084
Gender  0:212 (0:17)  0.549 0.125  0:096
Paranoid PD 4 (1:9) 4:03 (0:38)  0:337 (0:56)  1.446 0.772  0:043
Schizoid PD 4 (1:9) 3:45 (1:25)  0:949 (0:64)  2.215 0.317  0:122
Schizotypal PD 1 (0:05) 3:8 (–) 0:011 (1:27)  2.487 2.509 0:001
Antisocial PD 2 (1:0) 4:65 (1:20) 0:118 (0:78)  1.429 1.664 0:011
Borderline PD 29 (13:9) 4:34 (0:83)  0:058 (0:23)  0.512 0.396  0:019
Histrionic PD 3 (1:4) 3:87 (0:80)  0:676 (0:66)  1.969 0.617  0:075
Narcissistic PD 6 (2:9) 4:23 (0:78)  0:340 (0:47)  1.259 0.579  0:053
Avoidant PD 46 (22:0) 4:37 (1:03) 0:027 (0:21)  0.381 0.435 0:010
Dependent PD 17 (8:1) 4:46 (1:07) 0:134 (0:31)  0.471 0.739 0:034
Obsessive-compulsive PD 21 (10:0) 4:21 (1:03)  0:073 (0:26)  0.581 0.436  0:020
Self-defeating PD 11 (5:3) 4:79 (1:00) 0:545 (0:37)  0.187 1.276 0:114
Depressive PD 42 (20:1) 4:27 (1:03)  0:238 (0:22)  0.674 0.198  0:089
Negativistic PD 1 (0:05) 4:00 (–)  0:610 (1:12)  2.810 1.590  0:039
Personality disorder NOS 80 (38:3) 4:45 (1:00) 0:195 (0:17)  0.131 0.521 0:089
Any PD 131 (62:7) 4:36 (1:19)
No PD 78 (37:3) 4:41 (1:00)
SCQ, stigma consciousness questionnaire; PD, personality disorder; NOS, not otherwise specified; CI, confidence interval (95%).
The sum of the number of patients in the different diagnostic groups is higher than the total number of patients because patients can have more than one personality disorder.
*p<0.05; **p<0.01; ***p 0.001; R=0.25.
TABLE 3 |Mean DDQ scores for DSM-IV Axis II personality disorders (n=204).
N (%) SCQ M (SD) Analysis
B (SE) CI b
Lower bound Upper bound
Age  0:000 (0:00)  0.012 0:012 0:000
Gender  0:038 (0:13)  0.283 0:208  0:023
Paranoid PD 4 (2:0) 3:58 (0:50)  1:010 (0:40)  1.803  0:216  0:182*
Schizoid PD 4 (2:0) 4:53 (0:73)  0:102 (0:46)  1.008 0:805  0:018
Schizotypal PD 1 (0:5) 4:3 (–)  0:316 (0:91)  2.104 1:471  0:029
Antisocial PD 2 (1:0) 4:8 (0:71) 0:046 (0:56)  1.062 1:153 0:006
Borderline PD 27 (13:2) 4:63 (0:78) 0:110 (0:17)  0.226 0:447 0:049
Histrionic PD 3 (1:5) 3:97 (1:0)  0:620 (0:47)  1.545 0:305  0:097
Narcissistic PD 6 (2:9) 4:87 (0:84) 0:209 (0:33)  0.450 0:867 0:046
Avoidant PD 43 (21:1) 4:55 (0:74)  0:081 (0:152)  0.382 0:219  0:043
Dependent PD 17 (8:3) 4:34 (0:81)  0:271 (0:22)  0.706 0:165  0:097
Obsessive-compulsive PD 21 (10:3) 4:44 (0:62)  0:105 (0:19)  0.470 0:259  0:041
Self-defeating PD 11 (5:4) 4:5 (0:95) 0:046 (0:27)  0.479 0:571 0:014
Depressive PD 29 (19:1) 4:65 (0:74) 0:152 (0:16)  0.172 0:475 0:077
Negativistic PD 1 (0:5) 3:70 (–)  1:169 (0:80)  2.745 0:407  0:106
Personality disorder NOS 78 (38:2) 4:66 (0:74) 0:091 (0:12)  0.144 0:326 0:057
Any PD 127 (62:3) 4:58 (0:76)
No PD 77 (37:7) 4:64 (0:79)
DDQ, devaluation-discrimination questionnaire; PD, personality disorder; NOS, not otherwise specified; CI, confidence interval (95%).
The sum of the number of patients in the different diagnostic groups is higher than the total number of patients because patients can have more than one personality disorder.
*p<0.05; **p<0.01; ***p 0.001; R=0.28.
Stigma by Accumulative Personality Pathology
Table 4 shows that the experienced level of stigma does not
increase with an accumulating total number of PDs. There was
no effect of the total number of PDs on mean total stigma scores.
Although the patient groups with five or six PDs are small, it
is clear that there is no single tendency toward more stigma
associated with more PDs.
Discussion
This study aimed to investigate basic levels of stigmatization in
patients with PDs referred for intensive psychotherapeutic treat-
ment. Given the consistent emphasis in the literature on substan-
tial stigma in patients with PDs (11), the scientific evidence for
higher stigma in women with borderline PD compared to those
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TABLE 4 | SCQ (n=209) and DDQ (n=204) scores by the total number of
personality disorders (n=204–209)a.
Number of PDs SCQ DDQ
M SD M SD
No PD (n= 78/77)a 4.41 1.19 4.64 0.79
1 PD (n= 55/54)a 4.31 1.00 4.50 0.79
2 PDs (n= 35/34)a 4.51 0.98 4.79 0.80
3 PDs (n= 28/27)a 4.31 1.10 4.53 0.63
4 PDs (n= 9/8)a 4.46 1.02 4.78 0.62
5 PDs (n= 2) 3.55 0.21 4.65 0.64
6 PDs (n= 2) 4.40 0.42 3.20 0.00
SCQ, stigma consciousness questionnaire; DDQ, devaluation-discrimination question-
naire; PD, personality disorder.
aN varies due to missing values.
with social phobia (15), and the significant differences in
stigma between personality disordered adolescents and otherwise
psychiatrically disturbed adolescents (23), we expected remark-
able differences in stigma between patients with and with-
out PDs.
Results of our study were not in line with these expectations:
(1) mean total stigma scores were generally low in all patient
groups; (2) there was no impact of a diagnosis of PD on the
experienced stigma; (3) there was no effect of the number of
PDs on experienced stigma; and (4) there were no differences
found between different types of PDs. Only paranoid PD showed
significantly higher stigma scores on the DDQ, which can be
understood as inherent to this type of disorder: a basic lack of
trust in human interactions. The main result of the study is that
there are no differences in stigma between treatment-seeking
adults with or without PD. Similar studies with patient cohorts
consisting of different diagnostic categories (schizophrenia, major
depressive disorder, schizophrenia-like psychotic disorders and
adolescents with PD) showed marked higher stigma in all patient
groups (23, 29).
Several hypothetical explanations could explain our results.
First, there was bias in the features of the participants. All par-
ticipating patients had seven or more personality traits. Patients
from the non-personality disturbed group actually showed at
least tendency toward personality pathology. Although there were
clear differences in both groups concerning the classification
of a categorical personality diagnosis, we must consider over-
lap in personality characteristics. We can assume that our sam-
ple of patients was rather homogeneous regarding maladaptive
personality traits. Besides, all participants were all able to perform
a complex, demanding, and sometimes frustrating intake pro-
cedure, indicating that their personality organization was stable
enough to bear this task. More severely disturbed patients are not
admitted to the intake procedure, such as borderline patients with
documented serious self-harmful behavior. Second, an intense
intake procedure can give hope and improve self-esteem; patients
may be convinced that a careful approach and adherence to psy-
chotherapeutic treatment finally will lead to a better chance for
recovery. This hope and improved self-esteem can provide a buffer
for feelings of stigmatization. Third, the participants were not
yet involved in an intensive psychotherapeutic relationship with
a mental health professional, which is considered to be a serious
risk factor by several authors (16).
Other possible explanatory hypotheses are the nature of PDs,
with an overload of internalized problems that overflow exter-
nal attributions such as stigma. In addition, patients referred
for intensive psychotherapeutic treatment might not identify
themselves as psychiatric patients, who make the method and
questionnaires inappropriate methods for assessing this type of
information.
Limitations of the study were a bias in patient sample: per-
sonality disordered patients with severe behavioral disturbances
were excluded. Some patients from the SPECTRE-study refused
to participate in the stigma-study. It should be taken into account
that patients from a stigma-sensible environment could refuse to
participate in this study. We also must consider that some sub-
groups consist of only a very limited number of patients, which
therefore limit the interpretation. Another limitation in this study
is the lack of assessed Axis-I disorders, what makes it difficult to
describe the group of patients without PD. The current study’s
strengths are the large study cohort.
To the best of our knowledge, this is the first study to measure
stigma in a large sample of patients referred for intensive treat-
ment of PDs. Given the remarkable results, we would strongly
recommend further investigations in the field, both before and
after the psychotherapeutic treatment, comparing other diagnos-
tic groups and using other questionnaires, to better understand
the phenomenon.
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